Related Experiment Video
Updated: Jun 21, 2026
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
[Malignant mesothelioma]
1Service de pneumologie et oncologie thoracique, hôpital Calmette, CHRU de Lille, Faculté de médecine Henri-Warembourg, université de Lille-II, unité Inserm 774, Lille. a-scherpereel@chru-lille.fr
Abstract:
Malignant pleural mesothelioma (MPM) is an agressive and rare tumour, but with increasing incidence linked to previous exposure to asbestos fibers, its main etiological factor. The interest for this cancer has been stimulated by recent improvements in the diagnosis and in the treatment of mesothelioma, including new cytotoxic drugs and multimodal treatment, associating chemotherapy, radical surgery and radiotherapy in prospective, randomised and multicentric trials. The management of MPM is now better defined by the guidelines from the experts Conference of the Société de Pneumologie de Langue Française in 2005, actualised this year by the European Respiratory Society.
Insights
Malignant pleural mesothelioma (MPM) is a rare but aggressive cancer linked to asbestos exposure. Recent advancements in diagnosis and multimodal treatments are improving patient management and outcomes.
Area of Science:
- Oncology
- Pulmonology
- Environmental Health
Context:
- Malignant pleural mesothelioma (MPM) is a rare and aggressive thoracic malignancy.
- Increasing incidence is linked to asbestos fiber exposure, the primary etiological factor.
- Growing interest in MPM is driven by recent diagnostic and therapeutic advancements.
Purpose:
- To summarize current understanding and management of malignant pleural mesothelioma.
- To highlight recent improvements in diagnosis and treatment strategies.
- To provide an overview of updated expert guidelines for MPM management.
Summary:
- MPM is an aggressive tumor with rising incidence due to asbestos exposure.
- Advances include new cytotoxic drugs and multimodal treatments (chemotherapy, surgery, radiotherapy).
- Management is guided by updated expert conference guidelines from the European Respiratory Society.
Impact:
- Improved diagnostic capabilities for MPM.
- Enhanced therapeutic options, including multimodal approaches.
- Standardized clinical management based on current expert guidelines.
Related Concept Videos
01:30Pleural Disorders: Types and Brief Description
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...